Not Applicable
Not Applicable
The present invention relates to apparatuses, systems and methods for the treatment of aneurysms in the vasculature of patients. More particularly, the present invention relates to the treatment of abdominal aortic aneurysms.
An aneurysm is the focal abnormal dilation of a blood vessel. The complications which arise from aneurysms can include rupture, embolization, fistularisation and symptoms related to pressure on surrounding structures. Aneurysms are commonly found in the abdominal aorta, being that part of the aorta which extends from the diaphragm to the point at which the aorta bifurcates into the common iliac arteries. These abdominal aortic aneurysms typically occur between the point at which the renal arteries branch from the aorta and the bifurcation of the aorta.
When left untreated, an abdominal aortic aneurysm may eventually cause rupture of the aorta with ensuing fatal hemorrhaging in a very short time. High mortality associated with the rupture has led to the development of transabdominal surgical repair of abdominal aortic aneurysms. Surgery involving the abdominal wall, however, is a major undertaking with associated high risks. There is considerable mortality and morbidity associated with this magnitude of surgical intervention, which generally involves replacing the diseased and aneurysmal segment of blood vessel with a prosthetic device which typically includes a synthetic tube, or graft, usually fabricated of either a Dacron® polyester, a Teflon® polytetrafluoroethylene, or other suitable material.
To perform the surgical procedure, the aorta is exposed through an abdominal incision which can extend from the rib cage to the pubis. The aorta is closed both above and below the aneurysm, so that the aneurysm can then be opened and the thrombus, or blood clot, and arteriosclerotic debris removed. Small arterial branches from the back wall of the aorta are tied off The synthetic tube, or graft, of approximately the same size of the normal aorta is sutured in place, thereby replacing the aneurysm. Blood flow is then reestablished through the graft.
Disadvantages associated with the conventional surgery, in addition to the high mortality rate can include an extended recovery period associated with such surgery, difficulties in suturing the graft, or tube, to the aorta, loss of the existing aorta wall and thrombosis to support and reinforce the graft, unsuitability of the surgery for many patients having abdominal aortic aneurysms, and problems associated with performing the surgery on an emergency basis after the aneurysm has ruptured. As to the extent of recovery, a patient can expect to spend from 1 to 2 weeks in the hospital after the surgery (a major portion of which is spent in the intensive care unit) and a convalescence period at home from 2 to 3 months, particularly if the patient has other illness such as heart, lung, liver, and/or kidney disease (in which case the hospital stay is also lengthened).
A less invasive clinical approach to aneurysm repair is known as endovascular grafting. Endovascular grafting typically involves the transluminal placement of a prosthetic arterial graft within the lumen of the artery. The graft may be attached to the internal surface of an arterial wall by means of attachment devices (often similar to expandable stents), one above the aneurysm and a second below the aneurysm. Such attachment devices permit fixation of a graft to the internal surface of an arterial wall without sewing. Expansion of radially expandable stents is conventionally accomplished by dilating a balloon at the distal end of a balloon catheter. These balloon-expandable stents have found experimental and clinical application for endovascular treatments. U.S. Pat. No. 4,776,337 may be an example of such a stent. Also known are self expanding stents, such as described in U.S. Pat. No. 4,655,771 by Wallsten. These patents are hereby incorporated in their entireties, by reference.
Attachment of the device above and below the aneurysm is a conceptually straightforward procedure when the aortic aneurysm is limited to the abdominal aorta and there are significant portions of normal tissue above and below the aneurysm. Unfortunately, many aneurysms do not have suitable neck portions of normal tissue at the caudal portion (farthest from the head) of the aorta. Also, severe tortuosity of the iliac arteries and marked angulation of the aortoiliac junction can compound the difficulty of fixing the device in the caudal portion of the aorta. This situation can be exacerbated by the tendency of the abdominal aortic artery to elongate caudally during aneurysm formation. For want of sufficient normal aortic tissue to suitably attach a prosthetic graft at the caudal end of an aneurysm, or because of extension of the aneurysmal sac into the iliac arteries, bifurcated grafts have been developed that comprise a single body terminating with two limbs.
Typically, bifurcated grafts which are delivered endoluminally have an elongate flexible graft material attached to one or more anchors that support the flexible graft and serve to retain the graft in the deployed location in the blood vessel with reduced risk of the graft migrating from its deployed position. The anchor(s) is radially contractible and expandable between a reduced diameter, low profile configuration in which it can be inserted percutaneously into the patient's blood vessel and an expanded configuration in which the anchor(s) is deployed in the blood vessel and engages the inner luminal surface of the blood vessel sufficiently and in a manner to reduce the risk of the graft assembly migrating from its deployed location. In order to further reduce the risk of migration, the device may be provided with one or more hooks that can engage the wall of the blood vessel when the anchor is expanded. Although the use of such hooks is considered to be highly desirable, they may present some difficulty during delivery. For delivery, the device is contracted to a deliverable configuration. Typically the hooks extend radially outwardly which poses difficulties in both contracting the device into the deliverable configuration and in delivering the device to the blood vessel. For example, the hooks may become caught on a portion of the delivery device or may become caught with each other as the device is radially contracted. Should any of the hooks become caught, the ability of the device to properly expand upon delivery to the blood vessel may be impaired. This may interfere with the ability of the device to be positioned initially or repositioned by the delivery device. In addition, since expansion is typically achieved by release of constraining forces upon the device, the device usually self-expands as it is advanced from the confines of the delivery device. With the hooks extending radially outwardly to penetrate the vessel wall, the hooks can become caught on the delivery device or any other surface or structure as the device is self-expanding. This can damage the delivery device, the device itself and the surrounding blood vessel. Further, the addition of such hooks to the graft complicates the manufacturing process of the graft, adding additional time, cost and potential sources of failure.
It would be desirable, therefore, to provide apparatuses, systems and methods that provide the advantages of using hook-like elements to securely engage the blood vessel wall but in which the hook-like elements can be easily incorporated into the graft design, can be contracted for delivery and deployed with reduced risk of the elements becoming entangled, can provide increased resistance to graft migration and leakage, and can improve the characteristics of the surrounding tissue once in place. Further, such apparatuses and systems should not complicate the manufacturing process, reducing time, cost and potential sources of failure. It is among the general objects of the invention to provide such devices and techniques for their use.
The present invention provides apparatuses, systems and methods for repairing aneurysms in the vasculature of a patient. An aneurysm is repaired by positioning a tube or graft within the vasculature, extending through the region of the aneurysm to provide a blood flow conduit similar to the native vasculature. The tube is held in place within the vasculature by at least one expandable body having at least one microstructure. The microstructures are attached to the expandable body in a low profile fashion suitable for atraumatic introduction to the vasculature with the use of a catheter or other suitable device. Each microstructure has an end which is attached to the expandable body and a free end. Once the apparatus is positioned within the vasculature in the desired location, the microstructures are deployed so that the free ends project radially outwardly. The free ends of the deployed microstructures then penetrate the blood vessel wall by continued expansion of the body.
The microstructures provide a variety of functions. To begin, by penetrating the walls of the blood vessel, the microstructures firmly anchor the tube to the vessel wall therefore reducing the incidence of leaks at the time of deployment and throughout the life of the device. In addition, the microstructures reduce migration of device along the blood vessel. Such migration which could lead to leakage, exposure of the aneurysm and damage to the blood vessel, to name a few. In addition, the microstructures prevent apparent migration of the apparatus which occurs when the aneurysmal sac grows in size and as such encroaches upon the ends of the apparatus. This results in a reduction of the distance between the terminus of the apparatus and the aneurysm which is the same effect as migration. Thus, the anchoring microstructures help maintain intimate contact between the apparatus and the vessel wall and prevent aneurysmal sac growth.
The microstructures can also be used to deliver therapeutic agents to the blood vessel, the blood vessel walls and/or the outer surface of the blood vessel. Therapeutic agents such as VEGF, thrombin or collagen may be delivered into the vessel wall or deposited on the inner or outer surfaces of the vessel wall to enhance sealing by encouraging re-endothelialization and tissue regrowth or extra-cellular matrix formation. These agents may also be delivered to the aneurysmal sac. Agents such as VEGF, thrombin or collagen may also allow for tissue regrowth within the sac S, strengthening the tissue within the aneurysmal walls. Likewise, any suitable therapeutic agents may be delivered, including include drugs, DNA, genes, genes encoding for vascular endothelial growth factor, other therapeutic agents or any combination of these.
The one or more expandable bodies may be attached to the tube, such as attached to a surface of the tube wall or formed in the tube wall, or may be separate from the tube but positionable within the tube so that expansion of the expandable body penetrates the microstructures through the tube wall. In either situation, the expandable bodies may be disposed at any location along the length of the tube and may extend over a various portions of the tube, including extending along the entire tube. Likewise, microstructures may be arranged randomly or in patterns along the entire length or specific portions of the expandable bodies. For example, a plurality of microstructures may be positioned to project radially outwardly from the tube near each of its ends; this arrangement may be particularly suitable for anchoring the tube on opposite sides of the aneurysm. Other arrangements may be more suitable for other functions. For example, a plurality of microstructures may be positioned near the middle of the tube for delivery of therapeutic agents to the aneurysmal sac. Further, the deployed microstructures may project radially outwardly at various angles and to various heights. This may facilitate certain functions such as targeting specific tissue structures or layers within the vessel wall.
Although many microstructure designs are within the scope of the present invention, preferred embodiments of the microstructures have an attached end attached to the expandable body and a free end in an undeployed position, as mentioned above. In some embodiments, expansion of the body creates forces which deploy the at least one microstructure from the undeployed position to a deployed position wherein the free end projects radially outwardly. In the undeployed position, the microstructures are typically substantially aligned with an outer surface or perimeter of the body. However, it may be appreciated that the microstructures may lie beneath the surface, just so as the free ends do not project substantially outward beyond the outer surface.
In some embodiments, the at least one microstructure has a directional axis between the free end and the attached end. Each microstructure may be arranged so that its directional axis extends along the longitudinal axis, such as in a parallel manner. Alternatively, each microstructure may be arranged so that its directional axis extends across the longitudinal axis at an angle, such as in a perpendicular manner. Thus, the expansion of the body may be utilized to deploy microstructures arranged in a variety of directions, each of which generally project radially outwardly. Although the deployed microstructures may extend radially any distance from the expandable body, a distance of between 1000 μm and 5000 μm is preferred.
The free ends of the microstructures may have any desired shape. For example, in preferred embodiments the free ends have a pointed shape. When the apparatus is positioned in a blood vessel, the pointed shapes of the free ends may assist in penetration of the blood vessel wall. The shape, size and tapering of each point may possibly guide the free end to a certain penetration depth, such as to a specified tissue layer. Similarly, the free end may have an arrow-shape. This arrow shape may reduce the ability of the free end from withdrawing from a blood vessel wall once penetrated. This may be useful when the microstructures are used for anchoring. It may be appreciated that microstructures throughout the apparatus may all have the same free end shape or the shapes may vary randomly or systematically.
Exemplary embodiments of expandable bodies having deployable microstructures are described and illustrated in Provisional Patent Application No. 60/421,404 (Attorney Docket No. 021258-000910US), incorporated herein by reference for all purposes. In most embodiments, the mechanical act of expansion of the body creates forces which deploy the microstructures.
In preferred embodiments, the expandable body comprises a series of interconnected solid sections having spaces therebetween, such as resembling a conventional vascular stent. However, in contrast to conventional stents, the at least one microstructure is formed by at least one of the solid sections. Expansion of the body creates forces within the body causing mechanical deformation of the solid sections. This in turn deploys the microstructures. Since the apparatus relies upon the utilization of such mechanical deformation of the body to deploy the microstructures, additional processing beyond conventional laser machining is not necessary to create the microstructures.
In preferred embodiments, each microstructure has first and second supports and a free end, the supports affixed to associate first and second adjacent portions of the radially expandable body. Expansion of the expandable body within the patient effects relative movement between the associated first and second portions of the expandable body, the relative movement deploying the microstructures.
The expandable body can have any shape including a cylindrical shape similar to the overall shape of conventional stents. These shapes, particularly cylindrical shapes, have a circumference. Thus, relative movement of the associated first and second portions of the expandable body may comprises circumferential movement of the first portion relative to the second portion. Although the associated first and second portions may move circumferentially as the body expands, the portions may or may not be circumferentially aligned. In some embodiments wherein the associated first and second portions are in circumferential alignment, the circumferential movement of the first portion relative to the second portion draws the free end toward the circumferential alignment. In some of these and other embodiments, the circumferential movement pulls the affixed ends of the first and second supports apart which moves the free end. When the expandable body includes an interior lumen configured for receiving an expandable member, movement of the free end may create friction against the expandable member as the expandable member expands the expandable body, the friction projecting the free end radially outwardly.
In some preferred embodiments, the first and second supports comprise elongate shafts extending between the free end and the associated first and second adjacent portions of the radially expandable body. The relative movement of the associated first and second portions of the expandable body may comprise moving the associated first and second portions apart so that the supports pull the free end in opposite directions causing the free end to project radially outwardly. Often the elongate shafts are adjacent to each other and aligned with a circumference of the expandable body in the undeployed position. Thus, expansion of the body maintains the adjacent positioning of the shafts but moves them apart.
In some preferred embodiments, each microstructure further includes a third support affixed to an associated third portion of the radially expandable body, the associated first and third portions being connected so as to move in unison. Often, the first, second and third supports comprise elongate shafts attached to the free end and the associated first, second and third adjacent portions of the radially expandable body, respectively. Typically, the second support is disposed longitudinally between the first and third supports. Thus, the relative movement of the associated first and second portions of the expandable body can move the associated first and second portions apart while the associated third portion moves in unison with the associated portion so that the supports pull the free end in opposite directions forming a tripod structure which projects the free end radially outwardly.
Expansion of the expandable body may be achieved by any suitable means, such as by inflation of an expandable member, such as a balloon, within the body or by self-expansion. Typically the bodies are comprised of stainless steel, titanium, tantalum, vanadium, cobalt chromium alloys, polymers, or shape-memory alloys, such as nickel-titanium alloys, which are particularly suitable for self-expansion.
In addition, as mentioned previously, a material or therapeutic agent may be carried by the at least one microstructure, wherein the material is delivered to the patient upon deployment of the apparatus. The material may be coated on a surface of the at least one microstructure or held in a lumen within the at least one microstructure.
The systems and apparatuses of the present invention are sized for positioning within a blood vessel. Since aneurysms may be found in blood vessels of various sizes, such as ranging from small diameter cerebral arteries to large diameter regions of the aorta, embodiments of the present invention may be provided in a wide range of sizes. Likewise, the embodiments may be shaped to fit within specific anatomical geometries of the vasculature, such as bifurcations. This is particularly the case when repairing abdominal aortic aneurysms near the bifurcation of the aorta into the iliac arteries. Thus, embodiments of the present invention are provided to include legs or branches to fit within the iliac arteries or separate parts which fit within the iliac arteries and join together to form the complete apparatus in situ. Such joining may be achieved by standard methods or with the use of an additional expandable body. When an expandable body is used, the separate parts are fixed together by penetrating the microstructures through the walls of the parts. The microstructures may then optionally further penetrate the vessel wall.
Other objects and advantages of the present invention will become apparent from the detailed description to follow, together with the accompanying drawings.
The following detailed description illustrates the invention by way of example, not by way of limitation of the principles of the invention. Referring to
The tube 2 preferably has a generally, circular cross-sectional configuration, and may be made from a variety of materials. Examples of such materials are Dacron® and other polyester materials, Teflon® (polytetrafluoroethylene), Teflon® coated Dacron® material and porous polyurethane, to name a few. Generally, the tube material possesses the requisite strength characteristics to be utilized as a vascular graft, particularly an aortic graft when used to repair abdominal aortic aneurysms, as well as have the requisite compatibility with the human body in order to be used as a graft, or implant material, without being rejected by the patient's body. The material can be knitted or woven, and can be warp or weft knitted. If the material is warp knitted, it may be provided with a velour, or towel like surface, which may speed up clotting of blood upon contact with the tube 2 in order to increase the attachment, or integration, of tube 2 to the vessel or aorta. When the apparatus 10 is utilized to repair an aneurysm, such as to create an artificial conduit, it would be preferable to make tube 2 of a fluid impervious material.
The expandable body 12 typically comprises a series of interconnected solid sections having spaces therebetween. The solid sections are comprised of stainless steel, shape memory alloys, titanium, tantalum, vanadium, cobalt chromium alloys, polymers, or a combination of these. Thus, the expandable body 12 forms a type of scaffolding which is attached to the tube 2. The body 12 may be attached to the outside of the tube 2, the inside of the tube 2, and/or attached in a manner so that it lies within the wall 8 of the tube 2.
The expandable body 12 of the present invention may resemble conventional 30 stents and may be similarly manufactured, however the particular design of the structure is dependent, in part, upon the microstructures and the way that they deploy upon expansion of the body 12. As mentioned previously, exemplary embodiments of expandable bodies having deployable microstructures are described and illustrated in Provisional Patent Application No. 60/421,404 (Attorney Docket No. 021258-000910), incorporated herein by reference for all purposes. In most embodiments, the mechanical act of expansion of the body 12 creates forces which deploy the microstructures 14.
Referring to
Referring to
It may be appreciated that the expandable body 12 of
The free ends 32 of the microstructures 14 depicted in
Alternatively, such projection may be due to other factors, such as the direction of movement of the supports 37a, 37b, the shape of the supports 37a, 37b, or a combination of factors. For example,
It may be appreciated that any number of microstructures 14 may be present and may be arranged in a variety of patterns along the entire length of the body 12 or along any subportion. For example,
In addition, the deployed microstructures 14 may vary in height and in location.
Referring now to
Referring now to
When the expandable body 12 is positioned within the tube 2, expansion of the body 12 and deployment of the microstructures 14 occurs within the tube 2 so that further expansion penetrates the microstructures 14 through the tube wall 8, as illustrated in
As mentioned previously, the present invention may be utilized for any sort of treatment which involves delivery of a therapeutic agent and/or anchoring of a device. The devices could be introduced into various body lumens, such as the vascular system, lungs, gastrointestinal tract, urethra or ureter. The function of the microstructures includes but is not limited to facilitating drug and gene delivery, securing the device in place and providing a mechanical seal to the lumen wall. Thus, the present invention is particularly suited for repair of aneurysms within the vascular system.
Positioning of the apparatus of the present invention is typically performed via standard catheterization techniques. These methods are well known to cardiac physicians and are described in detail in many standard references. In brief, percutaneous access of the vasculature is obtained with standard needles, guide wires, sheaths, and catheters. After engagement of the blood vessel containing the aneurysm with a hollow guiding catheter, a guidewire is passed across the portion of the blood vessel where the apparatus is to be deployed. The apparatus is then passed over this guidewire, using standard coronary interventional techniques, to the site where the apparatus is to be deployed. Typically, this site is within the aneurysm so that the apparatus 10 straddles the aneurysm, extending between the upper neck UN and the lower neck LN as illustrated in
The microstructures 14 improve the performance of the apparatus 10 in a variety of ways. For instance, the microstructures 14 firmly anchor the apparatus to the vessel wall therefore reducing the incidence of leaks at the time of deployment of the apparatus. Also, the pressure from the blood flow through the apparatus further reduces migration and prevents leakage from the apparatus over time. In addition, the microstructures prevent apparent migration which occurs when the aneurysmal sac grows in size and as such encroaches upon the first and second ends of the apparatus. This results in a reduction of the distance between the terminus of the apparatus and the aneurysm. Thus, the anchoring microstructures help maintain intimate contact between the apparatus and the vessel wall and prevent aneurysmal sac growth.
The microstructures 14 can also be used to delivery therapeutic agents. Therapeutic agents such as VEGF, thrombin or collagen may be delivered into the vessel wall or deposited on the inner or outer surfaces of the vessel wall to enhance sealing by encouraging re-endothelialization and tissue regrowth or extra-cellular matrix formation. These agents may also be delivered to the aneurysmal sac S, as illustrated in
The present invention may be particularly suitable for repair of abdominal aortic aneurysms. An abdominal aortic aneurysm is a sac caused by an abnormal dilation of the wall of the aorta, a major artery of the body, as it passes through the abdomen. The abdomen is that portion of the body which lies between the thorax and the pelvis. It contains a cavity, known as the abdominal cavity, separated by the diaphragm from the thoracic cavity and lined with a serous membrane, the peritoneum. The aorta is the main trunk, or artery, from which the systemic arterial system proceeds. It arises from the left ventricle of the heart, passes upward, bends over and passes down through the thorax and through the abdomen to about the level of the fourth lumbar vertebra, where it divides into the two common iliac arteries at a bifurcation.
To treat abdominal aortic aneurysms, the apparatus 10 is shaped to be disposed at least partially within the aneurysm. In particular, the tube 2 is shaped to fit the aortic geometry. For example,
In another example, shown in
An expandable body may alternatively be positioned around the opening 80 on or within the tube 2 to attach the tube 2 to the additional tube 82. And, in general, it may be appreciated that any number of expandable bodies may be used. In particular, the additional tube 82 may be joined to the tube 2 without the use of the third expandable body 94.
Referring now to
It may be appreciated that the expandable body 12 may alternatively be embedded in the tube wall 8 or positioned within the tube 2 so that the microstructures 14 penetrate into and optionally through the wall 8 radially outwardly from the tube 2. Again, the first end 4 may be inverted to cover the microstructures 14. Further, the microstructures 14 may optionally be long enough to penetrate through the inverted first end 4 to then penetrate into the surrounding vessel wall.
In another example, shown in
In any case, the microstructures 14 may take any form described above and be deployable to project radially outwardly. The microstructures 14 then penetrate the extension cuff 120, 120′ and/or the tube 2 to attach the cuffs 120 to the tube 2. The microstructures 14 may only partially penetrate or may penetrate through and continue to penetrate through to the surrounding vessel when positioned in a patient. It may be appreciated that although extension cuffs 120, 120′ are illustrated near the ends of each of the main shaft 61 and first leg 62, respectively, cuffs 120, 120′ may be utilized at any or all of the ends of the device 10. Further, as illustrated in
Although the invention has been described in detail in the foregoing embodiments for the purpose of illustration, it is to be understood that such detail is solely for that purpose and that variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention except as it may be described by the following claims.
This application claims the benefit and priority of U.S. Provisional Patent Application No. 60/395,180 (Attorney Docket 021258-000900US) filed Jul. 11, 2002, U.S. Provisional Patent Application No. 60/421,404 (Attorney Docket 021258-000910US) filed Oct. 24, 2002, U.S. Provisional Patent Application No. 60/421,350 (Attorney Docket 021258-000700US) filed Oct. 24, 2002, and U.S. Provisional Patent Application No. 60/428,803 filed Nov. 25, 2002, the full disclosures of which are hereby incorporated by reference for all purposes. Also, this application is related to PCT Application No. ______ (Attorney Docket 021764-000920PC), filed on the same day as this application, the full disclosure of which is hereby incorporated by reference for all purposes.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US03/21611 | 7/11/2003 | WO | 10/16/2006 |
Number | Date | Country | |
---|---|---|---|
60395180 | Jul 2002 | US | |
60421404 | Oct 2002 | US | |
60421350 | Oct 2002 | US | |
60428803 | Nov 2002 | US |